Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients

Front Immunol. 2021 Oct 4:12:779064. doi: 10.3389/fimmu.2021.779064. eCollection 2021.

Authors

Leila B Giron¹, Harsh Dweep¹, Xiangfan Yin¹, Han Wang¹, Mohammad Damra¹, Aaron R Goldman¹, Nicole Gorman¹, Clovis S Palmer^{2

3}, Hsin-Yao Tang¹, Maliha W Shaikh⁴, Christopher B Forsyth^{4

5}, Robert A Balk⁵, Netanel F Zilberstein⁵, Qin Liu¹, Andrew Kossenkov¹, Ali Keshavarzian^{4

5}, Alan Landay⁵, Mohamed Abdel-Mohsen¹

Affiliations

¹ The Wistar Institute, Philadelphia, PA, United States.
² The Burnet Institute, Melbourne, VIC, Australia.
³ Department of Infectious Diseases, Monash University, Melbourne, VIC, Australia.
⁴ Rush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, United States.
⁵ Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.686240.].

Keywords: COVID-19; SARS-CoV-2; glycomics; inflammation; lipidomics; metabolomics; microbial translocation; zonulin.

Copyright © 2021 Giron, Dweep, Yin, Wang, Damra, Goldman, Gorman, Palmer, Tang, Shaikh, Forsyth, Balk, Zilberstein, Liu, Kossenkov, Keshavarzian, Landay and Abdel-Mohsen.

Publication types

Published Erratum